Bergstrom Donald A's Form 4 filing
Relay Therapeutics, Inc. (RLAY) · filed Apr 30, 2025
- Accession no.
- 0000950170-25-061365
- Filed
- Apr 30, 2025
- Trade date
- Apr 28-30, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $95.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bergstrom Donald ACIK 0001709772 | Officer (President, R&D) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 28, 2025 | Common Stock | SSaleDisposed | −4,090 | $3.17 | −$12,965.3 | 610,962 | Direct | |
| Apr 30, 2025 | Common Stock | SSaleDisposed | −27,472 | $3.00 | −$82,416 | 583,490 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.